Research Use Only: All products referenced are for laboratory and scientific research purposes
4 Efforts to extend the life of native GLP-1 led to the development of human GLP-1 analogs liraglutide, albiglutide, dulaglutide, and semaglutide
[267] In another randomized study published in 2003 (Meneilly et al.), 16 elderly, insulin-nave patients with diabetes were divided in two groups of 8 patients each, and given either a continuous subcutaneous infusion of GLP-1 at an initial dose of 100 pmol/kg/h, titrated up to a maximum dose of 120 pmol/kg/h for 12 weeks, compared to controls treated with conventional therapy
This includes dietary inputs, microbial balance, and targeted interventions that support long-term signaling stability
In Phase 3 trials, retatrutide 12 mg achieved 28.7% body weight reduction at 68 weeks, while mazdutide 9 mg achieved 20.1% at 60 weeks
Because GLP-1 agonists have many different pathways in the body they work through, sexual health effects may be different in different people